Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas

Cancer Genetics and Cytogenetics

Volumn 110, Issue 2, 1999, Pages 103-110

  Lamszus, Katrin ^a   Kluwe, Lan ^a   Matschke, Jakob ^a   Meissner, Hildegard ^a   Laas, Rudolf ^a   Westphal, Manfred ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BRAIN CANCER; CHROMOSOME 10Q; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 9Q; CYTOGENETICS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MENINGIOMA; PRIORITY JOURNAL; SARCOMA; TUMOR RECURRENCE;

ADULT; AGED; ALLELES; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; DISEASE PROGRESSION; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; SARCOMA;

EID: 0033561083     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00209-X     Document Type: Article

References (25)

1. Lantos P.L., VandenBerg S.R., Kleihues P. Tumours of the nervous system. Graham D.I., Lantos P.L. Greenfield's Neuropathology, Vol. 2. Sixth Ed:1997;583-795 Arnold, London.
2. Louis D.N., Budka H., von Deimling A. Meningiomas. Kleihues P., Cavenee W.K. Pathology and Genetics of Tumours of the Nervous System. 1997;134-141 International Agency for Research on Cancer, Lyon.
3. Kleihues P., Burger P.C., Scheithauer B.W. Histological Typing of Tumours of the Central Nervous System. 1993;Springer, Berlin.
4. Simon M., von Deimling A., Larson J.J., Wellenreuther R., Kaskel P., Waha A., Warnick R.E., Tew J.M. Jr., Menon A.G. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas. a genetic model of meningioma progression Cancer Res. 55:1995;4696-4701.
5. Weber R.G., Boström J., Wolter M., Baudis M., Collins P., Reifenberger G., Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas. toward a genetic model of meningioma progression PNAS USA. 94:1997;14719-14724.
6. Dumanski J.P., Carlborn E., Collins V.P., Nordenskjöld M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci USA. 84:1987;59275-59279.
7. Zankl H., Zang K.D. Cytological and cytogenetical studies on brain tumors. IV. Identification of the missing G chromosome in human meningiomas as No. 22 by fluorescence technique. Humangenetik. 14:1972;167-169.
8. Westphal M., Hänsel M., Kunzmann R., Hölzel F., Herrmann H.D. Spectrum of karyotypic aberrations in cultured human meningiomas. Cytogenet and Cell Genet. 52:1989;45-49.
9. Ruttledge M.H., Sarrazin J., Rangaratnam S., Phelan C.M., Twist E., Merel P., Delattre O., Thomas G., Nordenskjöld M., Collins V.P., Dumanski J.P., Rouleau G.A. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet. 6:1994;180-184.
10. Lekanne Deprez R.H., Bianchi A., Groen N.A., Seizinger B.R., Hagemeijer A., van Drunen E., Bootsma D., Koper J.W., Avezaat C.J.J., Kley N., Zwarthoff E.C. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet. 54:1994;1022-1029.
11. Wellenreuther R., Kraus J.A., Lenartz D., Menon A.G., Schramm J., Louis D.N., Ramesh V., Gusella J.F., Wiestler O.D., von Deimling A. Analysis of the neurofibromatosis gene reveals molecular variants of meningioma. Am J Pathol. 146:1995;827-832.
12. Bello M.J., de Campos J.M., Kusak M.E., Vaquero J., Sarasa J.L., Pestana A., Rey J.A. Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosom Cancer. 9:1994;296-298.
13. Lekanne Deprez R.H., Riegman P.H., van Drunen E., Warringa U.L., Groen N.A., Stefanko S.Z., Koper J.W., Avezaat C.J.J., Mulder P.G.H., Zwarthoff E.C., Hagemeijer A. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropathol Exp Neurol. 54:1995;224-235.
14. Niedermayer I., Feiden W., Henn W., Steilen-Gimbel H., Steudel W.I., Zang K.D. Loss of alkaline phosphatase activity in meningiomas. a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1 J Neuropathol Exp Neurol. 56:1997;879-886.
15. Rempel S.A., Schwechheimer K., Davis R.L., Cavenee W.K., Rosenblum M.L. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res. 53:1993;2386-2392.
16. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Rarsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
17. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K.A., Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D.H.F., Tavtigian S.V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15:1997;356-362.
18. Boström J., Cobbers J.M.J.L., Wolter M., Tabatabai G., Weber R.G., Lichter P., Collins V.P., Reifenberger G. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res. 58:1998;29-33.
19. Menon A.G., Rutter J.L., von Satte J.P., Synder H., Murdoch C., Blumenfeld A., Martuza R.L., von Deimling A., Gusella J.F., Houseal T.W. Frequent loss of chromosome 14 in atypical and malignant meningioma. identification of a putative tumor progression locus Oncogene. 14:1997;611-616.
20. Tse J.Y.M., Ng H.K., Lau K.M., Lo K.W., Poon W.S., Huang D.P. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas. Human Pathol. 28:1997;779-785.
21. Nowell P.C. Mechanisms of tumor progression. Cancer Res. 46:1986;2203-2207.
22. Zhu J., Frosch M.P., Busque L., Beggs A.H., Dashner K., Gilliland D.G., Black P.M. Analysis of meningiomas by methylation- and transcription-based clonality assays. Cancer Res. 55:1995;3865-3872.
23. Wu J.K., MacGillavry M., Kessaris C., Verheul B., Adelman L.S., Darras B.T. Clonal analysis of meningiomas. Neurosurgery. 38:1996;1196-1201.
24. Joseph J.T., Lisle D.K., Jacoby L.B., Paulus W., Barone R., Cohen M.L., Roggendorf W.H., Bruner J.M., Gusella J.F., Louis D.N. NF2 gene analysis distinguishes hemangiopericytoma from meningioma. Am J Pathol. 147:1995;1450-1455.
25. Jääskeläinen J., Louis D.N., Paulus W., Plate K.H., Haltia M.J. Haemangiopericytoma. Kleihues P., Cavenee W.K. Pathology and Genetics of Tumours of the Nervous System. 1997;146-148 International Agency for Research on Cancer, Lyon.